CTOs on the Move

Menlo Therapeutics

www.menlotherapeutics.com

 
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Solomon Wang
 Director of Information Technology Profile

Funding

Menlo Therapeutics raised $50M on 07/18/2017

Similar Companies

Heritage Ministries

We are a not for profit human services ministries for Seniors. Our goal is to fulfill our mission to serve others. Our full continuum of care grows within our community. We welcome seniors in every stage, extending solutions and access to quality care to those who need it most.

NeoMend

NeoMend is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EsferaMed International

EsferaMed International is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Habilitation Svc

American Habilitation Svc is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Xealth

Xealth enables healthcare teams to order digital content and services as easily as they do medications today.